Company profile: Bluejay Diagnostics
1.1 - Company Overview
Company description
- Provider of the Symphony automated diagnostic system using fluorescence immuno-analysis for rapid testing with integrated reagents in single-use cartridges; Symphony cartridges for blood processing and ELISA of specific biomarkers; and the Symphony IL-6 test for near-patient monitoring of disease progression.
Products and services
- Symphony IL-6 Test: Near-patient diagnostic test developed for the Symphony platform to monitor disease progression by assessing the IL-6 biomarker in compatible workflows
- Symphony: Automated diagnostic system utilizing fluorescence immuno-analysis for rapid testing with integrated reagents in a single-use cartridge
- Symphony Cartridges: Single-use cartridges for the Symphony system, containing all necessary reagents for blood processing and ELISA of specific biomarkers
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bluejay Diagnostics
Calimmune
HQ: United States
Website
- Description: Provider of clinical-stage gene therapies, including a lead gene-based therapeutic candidate engineered to control HIV infection and protect individuals with HIV from progressing to AIDS. The therapy is currently being evaluated in Phase I/II studies. Cal-1 is designed to reduce production of CCR5, a protein.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calimmune company profile →
Micronics
HQ: United States
Website
- Description: Provider of near-patient in vitro diagnostic products for disease diagnosis, prognosis, and treatment monitoring in the United States and internationally, including the PanNAT molecular diagnostic system, a point-of-care testing instrument.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micronics company profile →
Qpex Biopharma
HQ: United States
Website
- Description: Provider of antibiotic agents addressing critical needs in infectious disease treatment and antimicrobial resistance for inpatient and outpatient care. Portfolio includes QPX7728, an ultra-broad-spectrum beta-lactamase inhibitor; OMNIvance (Xeruborbactam + Meropenem) for gram-negative infections; ORAvance, an oral Xeruborbactam prodrug enhancing oral beta-lactams; and QPX9003, a lipopeptide for MDR gram-negative pathogens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qpex Biopharma company profile →
Proof Diagnostics
HQ: United States
Website
- Description: Provider of life sciences tools, diagnostics, and computational discovery solutions, offering a smart, portable CRISPR-based and other technology diagnostic system for rapid, low-cost, sensitive detection of infectious diseases (e.g., SARS-CoV-2, Flu A/B, RSV) and other diseases, OMEGA libraries of RNA-programmable non-Cas enzymes for genome engineering, and gene therapy services leveraging these tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proof Diagnostics company profile →
Poolbeg Pharma
HQ: Ireland
Website
- Description: Provider of clinical-stage research and development of novel treatments for infectious diseases, including POLB 001, an oral small molecule for cancer immunotherapy-induced cytokine release syndrome and severe influenza; AI-powered drug discovery leveraging human challenge trial data; and an oral GLP-1 agonist delivery system targeting obesity and other metabolic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Poolbeg Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bluejay Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bluejay Diagnostics
2.2 - Growth funds investing in similar companies to Bluejay Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bluejay Diagnostics
4.2 - Public trading comparable groups for Bluejay Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →